Dextech Medical AB (DEXTECH)

Currency in SEK
7.950
-0.050(-0.63%)
Real-time Data·
DEXTECH Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
DEXTECH is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
7.5007.950
52 wk Range
3.6209.550
Key Statistics
Bid/Ask
7.60 / 7.95
Prev. Close
8
Open
7.6
Day's Range
7.5-7.95
52 wk Range
3.62-9.55
Volume
878
Average Volume (3m)
12.03K
1-Year Change
110.53%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
DEXTECH Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
High return over the last year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Dextech Medical AB Company Profile

Dextech Medical AB engages in the development of drug candidates with application in urological oncology, primarily prostate cancer. Its principal product candidate is OsteoDex that has completed phase IIb clinical trial for the treatment of skeletal metastases in castration resistant prostate cancer, as well as in preclinical stage to treat breast and lung cancer, as well as multiple myeloma. The company is also developing SomaDex, a medication candidate that is based on an endogenous hormone, somatostatin, to treat acromegaly, neuroendocrine tumors, and palliative treatment for advanced prostate cancer; and PSMA-binding conjugates for the target-specific treatment of mCRPC that overexpresses prostate specific membrane antigen (PSMA). In addition, the company offers GuaDex (formarly CatDex), a technology platform and a charge-modified dextran molecule with tumor-toxic properties used for medication development. Dextech Medical AB was incorporated in 2004 and is based in Uppsala, Sweden.

Compare DEXTECH to Peers and Sector

Metrics to compare
DEXTECH
Peers
Sector
Relationship
P/E Ratio
−31.9x−9.6x−0.5x
PEG Ratio
-−0.200.00
Price/Book
5.6x6.6x2.6x
Price / LTM Sales
34.9x42.3x3.3x
Upside (Analyst Target)
-11.0%43.5%
Fair Value Upside
Unlock7.0%6.9%Unlock

Earnings

Latest Release
Apr 29, 2025
EPS / Forecast
-0.07 / --
Revenue / Forecast
515.00K / --
EPS Revisions
Last 90 days

DEXTECH Income Statement

FAQ

What Stock Exchange Does Dextech Medical Trade On?

Dextech Medical is listed and trades on the Spotlight Stock Market stock exchange.

What Is the Stock Symbol for Dextech Medical?

The stock symbol for Dextech Medical is "DEXTECH."

What Is the Dextech Medical Market Cap?

As of today, Dextech Medical market cap is 146.96M.

What Is Dextech Medical's Earnings Per Share (TTM)?

The Dextech Medical EPS (TTM) is -0.25.

From a Technical Analysis Perspective, Is DEXTECH a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Dextech Medical Stock Split?

Dextech Medical has split 2 times.

How Many Employees Does Dextech Medical Have?

Dextech Medical has 1 employees.

What is the current trading status of Dextech Medical (DEXTECH)?

As of 07 Aug 2025, Dextech Medical (DEXTECH) is trading at a price of 7.95, with a previous close of 8.00. The stock has fluctuated within a day range of 7.50 to 7.95, while its 52-week range spans from 3.62 to 9.55.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.